Hypertensive diseases in pregnancy;Hypertensive schwangerschaftserkrankungen

Gynakologe

Volumn 32, Issue 6, 1999, Pages 432-442

  Rath, W ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Chronic hypertension; Early detection; Obstetric procedure; Pathogenesis; Preeclampsia; Preventative measures; Risk of recurrence

Indexed keywords

NITRIC OXIDE SYNTHASE;

DELIVERY; ECLAMPSIA; ENDOTHELIUM LESION; FEMALE; HELLP SYNDROME; HUMAN; INTENSIVE CARE; LIPID OXIDATION; MATERNAL HYPERTENSION; OBSTETRIC OPERATION; PATHOGENESIS; PATIENT MONITORING; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY TERMINATION; PROGNOSIS; REVIEW; SYNCYTIOTROPHOBLAST; VASOCONSTRICTION; VASODILATATION;

EID: 0032997538     PISSN: 00175994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001290050445     Document Type: Review

References (57)

1. Arngrimsson R, Hayward C, Nadand S et al. (1997) Evidence for a familial pregnancy-induced hypertensive locus in the eNOS-gene region. Am J Hum Genet 61: 354-362
2. Beck T (1992) Morphologische und hämodynamische Veränderungen der Plazenta bei Präeklampsie. Gynäkologe 25: 391-397
3. Bower S, Bewley S, Campbell S (1993) Improved prediction of preeclampsia by two-stage screening of uterine arteries using the early diastolic notch and color doppler imaging. Obstet Gynecol 82: 78-83
4. O'Brien WF (1992) The prediction of preeclampsia. Clin Obstet Gynecol 35: 351-364
5. Brosens JA, Robertson WB, Dixon HG (1972) The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Ann 1: 177-181
6. Buhimschi IA, Saade GR, Chwalisz K, Garfield RE (1998) The nitric oxide pathway in preeclampsia: pathophysiological implications. Hum Reprod Update 4: 25-42
7. Caritis S, Sibai BM, Hauth I et al. (1998) Low-dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med 338: 701-705
8. CLASP (1994) A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregment women. Lancet 343: 19-29
9. Davidge ST (1998) Oxidative stress and altered endothelial cell function in preeclampsia. Semin Reprod Endocrinol 16: 65-73
10. Dekker GA, de Vries JP, Doelitsch PM, Huijans PC, von Blomberg BME, van Geijn HP (1996) Underlying disorders associated with severe early onset preeclampsia. Am J Obstet Gynecol 173: 1042-1048
11. Dekker GA, Robillard PY, Hulsey TC (1998) Immun maladaptation in the etiology of preeclampsia: a review of corroborative epidemiologic studies. Obstet Gynecol Surv 53: 377-382
12. Dekker GA, Sibai BM (1998) Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 179: 1359-1375
13. Dizon-Townson DS, Nelson LM, Easton K, Ward K (1996) The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 175: 902-905
14. Friedberg V (1992) Pathophysiologie des Schwangerschaftshochdrucks. Gynäkologe: 370-385
15. Grunewald C (1997) Biochemical prediction of preeclampsia. Acta Obstet Gynecol Scand 76: 104-107
16. Halligan A, Shennon A, Thurston, H, de Swiet M, Taylor D (1995) Ambulatory blood pressure measurement in pregnancy: the current state of the art. Hypertension in Pregnancy 14: 1-16
17. Harms K, Rath W, Hertig E, Kuhn W (1995) Maternal hemolysis, elevated liver enzymes, low platelet count, and neonatal outcome. Am J Perinatol 12: 1-6
18. Harrington K, Carpenter RG, Goldfrad C, Campbell S (1997) Transvaginal doppler ultrasound of the uteroplacental circulation in the early prediction of preeclampsia and intrauterine growth retardation. Br J Obstet Gynaecol 104: 674-681
19. Harrison GA, Humphrey KE, Jones N, Badenkop R, Guo G et al. (1997) A genowide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4 q. Am J Hum Genet 60: 1158-1167
20. Heilmann L, Rath W, Wacker J (1998) Diagnostik, Therapie und geburtshilfliches Vorgehen bei schweren hypertensiven Schwangerschaftserkrankungen. Frauenarzt 39: 1706-1716
21. Heyl W, Handt S, Reister F, Gehlen J, Mittermayer C, Rath W (1999) The role of soluble adhesion molecules for evaluating endothelial cell activation in preeclampsia. Am J Obstet Gynecol 180: 68-72
22. Heyl W, Handt S, Reister F, Gehlen J, Rath W (1998) Zur Frage der Zytotoxizität von Präeklampsieserum - Immunfluoreszenzmikroskopische Untersuchungen an kultivierten humanen Endothelzellen. Geburtshilfe Frauenheilkd 58: 543-546
23. Deutsche Liga zur Bekämpfung des hohen Blutdrucks (1997) (Hrsg) Hochdruck in der Schwangerschaft und während der Stillperiode, 3. Aufl. Deutsche Liga zur Bekämpfung des hohen Blutdrucks, Heidelberg
24. Holzgreve W, Ghezzi F, Di Naro E, Ganshirt D, Maymon E, Hahn S (1998) Disturbed fetomaternal cell traffic in preeclampsia. Obstet Gynecol 91: 669-672
25. Katz VL, Watson WJ, Thorp JM, Hansen W, Bowes WA (1992) Treatment of persistent postpartum HELLP syndrome with plasmapheresis. Am J Perinatol 9: 120-122
26. Kaulhausen H (1992) Gestationshypertonie und Präeklampsie - klinische und biochemische Funktionstests in der Früherkennung und Basisdiagnostik. Gynäkologe 25: 386-390
27. Kilpatrick DC (1996) HLA-dependent TNF secretory response may provide an immunogenetic link between preeclampsia and type 1 diabetes mellitus. Dis Markers 13: 43-47
28. Knight M, Redman CW, Linton EA, Sargent IL (1998) Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynecol 105: 632-640
29. Krauss T, Kuhn W, Lakoma C, Augustin HG (1997) Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol 177: 443-449
30. Krauss T, Augustin HG, Osmers RG, Meden H, Unterhalt M, Kuhn W (1998) Activated protein C resistance and factor V Leiden in patients with HELLP-syndrome. Obstet Gynecol 92: 457-460
31. Levine RJ, Hauth JC, Curet LB et al. (1997) Trial of calcium to prevent preeclampsia. N Engl J Med 337: 69-76
32. Magann EF, Bass D, Chauhan SP, Sullivan DL, Martin RW, Martin JN (1994) Antepartum corticosteroids: Disease stabilization in patients with the HELLP-syndrome. Am J Obstet Gynecol 171: 1148-1153
33. Martin JN, Perry KG, Blake PG, May WA, Moore A, Robinette L (1997) Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP syndrome. Am J Obstet Gynecol 177: 1011-1017
34. Niesert S (1996) Geburtshilfliche Prognose nach Präeklampsie, Eklampsie und HELLP-Syndrom. Geburtshilfe Frauenheilkd 56: 93-96
35. Odendaal H, Pattinson RC, Baum R (1990) Aggressive or expectant management for patients with severe preedampsia between 28 and 34 weeks gestation: a randomized controlled trial. Obstet Gynecol 76: 1070-1075
36. Olah KS, Redman CW, Gee H (1993) Management of severe early preedampsia - is a conservative management justified? Eur J Obstet Gynecol Reprod Biol 51: 175-190
37. Pampus van MG, Wolf H, Westenberg SM, van der Post JAM, Bonsel J, Treffers PE (1998) Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 76: 31-36
38. Rath W, Schrader J (1993) Endothelin und Schwangerschaft. Zentralbl Gynäkol 115: 388-395
39. Rath W (1994) Das HELLP-Syndrom. Zentralbl Gynäkol 116: 195-201
40. Rath W (1996) Aggressives versus konservatives Vorgehen beim HELLP-Syndrom: eine Standortbestimmung. Geburtshilfe Frauenheilkd 56: 265-271
41. Rath W (1997) Die Behandlung hypertensiver Schwangerschaftserkrankungen - allgemeine Maßnahmen und orale Langzeittherapie. Z Geburtshilfe Neonatol 201: 240-246
42. Rath W, Faridi A (1999) Schwangerschaftsinduzierte Hypertonie - Risikominderung durch rationale Diagnostik und Therapie. Gynäkologe 32: 46-52
43. Reister F, Heyl W, Kaufmann P, Rath W (1998) Die gestörte Trophoblastinvasion bei Präeklampsie - eine Übersicht über neue Erkenntnisse zur Ätiologie. Geburtshilfe Frauenheilkd 58: 625-631
44. Roberts JM (1995) Endothial dysfunction yes, cytotoxicity no. Am J Obstet Gynecol 173: 978
45. Roberts JM (1998) Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16: 5-15
46. Ruschitzka F, Schulz E, Kling H, Schrader J, Rath W (1996) Longitudinalstudie zum 24-h-Blutdruckverhalten in Schwangerschaft und Wochenbett bei Patientinnen mit normaler Schwangerschaft, Präeklampsie und HELLP-Syndrom. Z Geburthilfe Neonatol 200: 100-103
47. Sibai BM (1996) Treatment of hypertension in pregnant women. N Engl J Med 335: 257-265
48. Sibai BM (1998) Prevention of preeclampsia: a big disappointment. Am J Obstet Gynecol 179: 1275-1278
49. Sibai BM, Ramadan MK, Chari RS, Friedman SA (1995) Pregnancies complicated by HELLP-syndrome: Subsequent pregnancy outcome and long-term prognosis. Ann J Obstet Gynecol 172: 125-129
50. Sibai BM, Mercer BM, Schiff E, Friedman SA (1994) Aggressive versus expectant management of severe preeclampsia at 28-32 weeks gestation - a randomized controlled trial. Am J Obstet Gynecol 171: 818-822
51. Standards in der Perinatalmedizin: Dopplersonographie in der Schwangerschaft (1996) Geburtshilfe Frauenheilkd M 69-73
52. Visser W, Wallenburg HCS (1995) Temporising management of severe preeclampsia with and without the HELLP-syndrome. Br J Obstet Gynaecol 102: 111-117
53. Walker JJ (1998) Antioxidants and inflammatory cell response in preeclampsia. Semin Reprod Endocrinol 16: 47-55
54. Walsh SW (1998) Maternal placental interaction of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrinol 16: 93-104
55. Welsch H (1997) Müttersterblichkeit während der Geburt und Wochenbett bei vaginaler Entbindung und Sectio caesarea. Gynäkologe 30: 742-756
56. Witlin AG, Sibai BM (1998) Hypertension. Clin Obstet Gynecol 41: 533-544
57. Zeeman GG, Dekker GA (1992) Pathogenesis of preeclampsia. Clin Obstet Gynecol 35: 317-333